ProGnosis Biotech S.A
ProGnosis Biotech is an innovative Biotechnology Company, specialized in developing next-generation immuno-assays for the food/feed & clinical diagnostics industries.
ProGnosis Biotech is an innovative Biotechnology Company, specialized in developing and manufacturing next-generation immuno-assays for the food/feed & clinical diagnostics industries.
Based in Larissa, Greece, and having offices in Thessaloniki, Madrid, and Beijing, ProGnosis Biotech is an export-oriented enterprise which through a large network of distributors, exports ELISA kits and Lateral-flow tests to more than 40 countries worldwide.
In order to consistently provide top-quality products, our company participates on a monthly basis in Proficiency Tests in the UK, France, Germany, Italy, and the US. Additionally, ProGnosis Biotech offers validated products from the most highly esteemed organizations worldwide, and all the R&D and production procedures are certified with ISO 9001.
“Accuracy Through Innovation”
Our mission is to provide innovative, accurate and simple solutions to the challenges presented in the food safety & clinical diagnostics industries. Our vision is to achieve a leading role in the diagnostics field by promoting consumers’ wellbeing based on high-quality standards
View All Product News
Microbiology Product Areas
|Antibodies||Show all suppliers|
|COVID-19 Antigen Test||Show all suppliers|
|COVID-19 IgG/IgM||Show all suppliers|
|ELISA||Show all suppliers|
Food & Beverage
|Aflatoxins||Show all suppliers|
|COVID-19/SARS2 Environment||Show all suppliers|
|Lateral Flow Assays||Show all suppliers|
|Mycotoxins||Show all suppliers|